CTKs: Therapeutic Targets for Chronic Diseases
Credit: Sino Biological
Cytoplasmic tyrosine kinases (CTKs) are essential regulators of cell growth, differentiation, and survival, playing critical roles in both normal physiology and disease. Dysregulation of CTK activity is linked to various cancers and chronic disorders, highlighting their importance in targeted therapies. Clinical trials assessing inhibitors for CTKs such as JAK, ABL, SYK, and SRC show promise for treating autoimmune diseases and cancers. SignalChem Biotech, now part of Sino Biological, offers a vast selection of CTKs across different species. These tools are crucial for advancing research into more effective targeted therapies for cancers and chronic diseases targeting CTKs.
